GlyCOVID

GlyCOVID is a dataset of RDFized COVID-19 data related to glycans. Resources will be added incrementally as publications are curated.

Longitudinal Development of Antibody Responses in COVID-19 Patients of Different Severity with ELISA, Peptide, and Glycan Arrays: An Immunological Case Series.
Heidepriem J, et al.
Pathogens. 2021; 10(4):438. https://doi.org/10.3390/pathogens10040438

A longitudinal analysis of three COVID-19 patients with moderate (#1) and mild disease (#2 and #3) was published. Antibody serum responses were analyzed using spike glycoprotein enzyme linked immunosorbent assay (ELISA), full-proteome peptide, and glycan microarrays. In this Glycovid dataset, the data from these glycan microarray experiments have been RDFized. Fluorescence intensity is given in arbitrary fluorescence units (AFU) as reported in this publication.

Source Last Updated
PSICQUIC March 30, 2022
Displaying entries 2726 - 2750 of 4050 in total
Antibody Patient Onset (days) Symptom GlyTouCan ID ▲ Arbitrary Fluorescence Units (AFU)
IgM Patient 3 11 mild
G64669AQ
3180
IgM Patient 3 4 mild
G64669AQ
1821
IgA Patient 4 12 mild
G64669AQ
348
IgG Patient 4 12 mild
G64669AQ
158
IgM Patient 4 12 mild
G64669AQ
168
IgA Patient 1 10 moderate
G65889KE
433
IgA Patient 1 22 moderate
G65889KE
420
IgA Patient 1 6 moderate
G65889KE
380
IgG Patient 1 10 moderate
G65889KE
46
IgG Patient 1 22 moderate
G65889KE
45
IgM Patient 1 10 moderate
G65889KE
60
IgM Patient 1 22 moderate
G65889KE
62
IgG Patient 1 6 moderate
G65889KE
38
IgM Patient 1 6 moderate
G65889KE
37
IgA Patient 2 15 mild
G65889KE
291
IgA Patient 2 24 mild
G65889KE
332
IgG Patient 2 15 mild
G65889KE
70
IgG Patient 2 24 mild
G65889KE
82
IgM Patient 2 15 mild
G65889KE
95
IgM Patient 2 24 mild
G65889KE
107
IgA Patient 2 3 mild
G65889KE
320
IgG Patient 2 3 mild
G65889KE
87
IgM Patient 2 3 mild
G65889KE
143
IgA Patient 3 -180 mild
G65889KE
284
IgA Patient 3 11 mild
G65889KE
377

About Release Notes Help Feedback

International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01


Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International


GlyCosmos Portal v4.1.0

Last updated: December 9, 2024